MetroNIDAZOLE 0.75 % Topical Gel
RxNorm 311679
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 311679 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metroNIDAZOLE 0.75 % Topical Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Metronidazole 0.0075 mg/MG Topical Gel
(Atom ID: 12340619)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.0075 mg/MG Topical Gel
(Atom ID: 3742370)
PSNPrescribable
Prescribable Name (PSN):
MetroNIDAZOLE 0.75 % Topical Gel
(Atom ID: 6381290)
SYPrescribable
Synonym (SY):
Metronidazole 0.75 % Topical Gel
(Atom ID: 2984439)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.75 % Topical Gel
(Atom ID: 3729602)
PTPrescribable
Designated preferred name (PT):
Metronidazole 7.5 mg/g cutaneous gel
(Atom ID: 10301714)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely metronidazole 7.5 mg/1 gram conventional release cutaneous gel (clinical drug)
(Atom ID: 10314913)
Patient Education
Metronidazole Topical
Metronidazole is used to treat rosacea (a skin disease that causes redness, flushing, and pimples on the face). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.